Skip to main navigation Skip to search Skip to main content

Lipoic acid and lipoic acid analogs in cancer metabolism and chemotherapy

  • Cornerstone Pharmaceuticals, Inc
  • Stony Brook University

Research output: Contribution to journalReview articlepeer-review

50 Scopus citations

Abstract

The lipoic acid (lipoate) coenzyme is unique in all of mammalian metabolism. It is not only crucial to the function of some of the major enzymes feeding carbon into the tricarboxylic acid cycle, but also generates dynamic regulatory information about the metabolic status of the mitochondrial matrix, ultimately functioning to control these metabolic fluxes. Moreover, these lipoate-sensitive regulatory processes are apparently systematically redesigned in tumor cells and the affected enzymes commonly become especially central to cancer metabolism. Thus, lipoate-sensitive regulatory processes constitute potentially uniquely valuable targets for chemotherapeutic attack. Our goal here is to review the current status of our knowledge relevant to the use of lipoate and lipoate analogs to therapeutically attack malignant disease.

Original languageEnglish
Pages (from-to)837-846
Number of pages10
JournalExpert Review of Clinical Pharmacology
Volume7
Issue number6
DOIs
StatePublished - Nov 1 2014

Keywords

  • cancer metabolism
  • chemotherapy
  • lipoate
  • lipoate analogs
  • lipoic acid
  • lipoic acid analogs
  • tumor mitochondria
  • two compartment metabolism

Fingerprint

Dive into the research topics of 'Lipoic acid and lipoic acid analogs in cancer metabolism and chemotherapy'. Together they form a unique fingerprint.

Cite this